Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1

av Wheeler, T.M., Krym, M.C., Thornton, C.A.
Publicerad 2007

Signal transducer and activator of transcription-3 licenses Toll-like receptor 4-dependent interleukin (IL)-6 and IL-8 production via IL-6 receptor-positive feedback in endometrial...

av Cronin, J G, Kanamarlapudi, V, Thornton, C A, Sheldon, I M
I publikationen Mucosal Immunol (2016)

Health education in schools.

av Thornton, C A, Brennan, R K, Browne, A D, Denham, P C
Publicerad 1978

Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR.

av Tian, B, White, R J, Xia, T, Welle, S, Turner, D H, Mathews, M B, Thornton, C A
Publicerad 2000

Bioenergetic analysis of human peripheral blood mononuclear cells

av Jones, N, Piasecka, J, Bryant, A H, Jones, R H, Skibinski, D O F, Francis, Nigel J, Thornton, C A
I publikationen Clin Exp Immunol (2015)

Human gestation‐associated tissues express functional cytosolic nucleic acid sensing pattern recognition receptors

av Bryant, A. H., Menzies, G. E., Scott, L. M., Spencer‐Harty, S., Davies, L. B., Smith, R. A., Jones, R. H., Thornton, C. A.
I publikationen Clin Exp Immunol (2017)

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1 [Image: see text]

av Logigian, E.L., Martens, W.B., Moxley, R.T., McDermott, M.P., Dilek, N., Wiegner, A.W., Pearson, A.T., Barbieri, C.A., Annis, C.L., Thornton, C.A., Moxley, R.T.
Publicerad 2010

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

av Sorenson, E J., Windbank, A J., Mandrekar, J N., Bamlet, W R., Appel, S H., Armon, C, Barkhaus, P E., Bosch, P, Boylan, K, David, W S., Feldman, E, Glass, J, Gutmann, L, Katz, J, King, W, Luciano, C A., McCluskey, L F., Nash, S, Newman, D S., Pascuzzi, R M., Pioro, E, Sams, L J., Scelsa, S, Simpson, E P., Subramony, S H., Tiryaki, E, Thornton, C A.
Publicerad 2008